Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-06

Clinical Trial Update: Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance [Phase 2]

View source ↗

Summary

Phase 2 trial update on nepadu­tant in infants with feeding intolerance due to colic, reporting preliminary efficacy, safety, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nepadutant (nepadutant)

Snippet

Sponsor: Menarini Group | Conditions: Colic | Phase 2 | Status: COMPLETED | Results posted: 2023-05-06